MedTrace Logo

Stroke Therapy With Brain Oscillation Synchronized Stimulation

NCT05005780 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-08-18

No results posted yet for this study

Summary

This randomized, controlled, double-blind clinical pilot trial investigates the therapeutic potential of a novel personalized therapeutic brain-stimulation protocol in chronic stroke patients with spasticity. Stroke patients will either receive ipsilesional 100 Hz transcranial magnetic stimulation (TMS) triplet burst protocol synchronized to the ongoing µ-alpha oscillation or contralesional 1 Hz repetitive TMS (rTMS) protocol. Motor recovery is assessed directly after as well as three months after completion of the therapy.

Conditions

Interventions

DEVICE

Negative peak triggered 100 Hz triplet burst TMS

MagVenture MagPro X100: Ipsilesional negative peak triggered 100 Hz triplet burst TMS.

DEVICE

1 Hz rTMS

MagVenture MagPro X100: Contralesional 1 Hz rTMS.

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Ulf Ziemann, Prof. Dr. · University Hospital Tübingen, Department of Neurology and Stroke

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-02
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05005780 on ClinicalTrials.gov